From "dual registration" to the first drug administration: Wingor Biotech helps Guangxi achieve a breakthrough in stem cell clinical research.by adminDecember 18, 2025May 25, 2026
The Guangxi Cell Therapy Professional Committee was established! Wingor Biotech showcased its technological foresight at the first academic exchange conference.by adminDecember 1, 20252026年5月24日
Senior executives from Indonesian state-owned pharmaceutical company PT Bio Farma visited Innovent Biologics.by adminNovember 26, 2025May 25, 2026
Technological Innovation | Ingloun Biotechnology's "An Adaptive Cell Thawing Method and System Based on Multi-Parameter Feedback" Receives National Invention Patentby adminNovember 19, 2025May 25, 2026
At the forefront! The Medical Director of Ingenics shares clinical progress of WG103 stem cell injection for stroke treatment | 14th Beijing Cell Biology Industry Conferenceby adminNovember 14, 2025May 25, 2026
Experts from Ingenics Biotechnology were invited to attend the 3rd Greater Bay Area Cell and Gene Therapy Development Forum 2025 and deliver a keynote speech.by adminNovember 12, 2025May 25, 2026
Inglos Biopharma presents "Exploring the Commercialization Path of Cell Therapy: Drugs vs. New Biomedical Technologies" | 2025 Hainan Cell Therapy Conferenceby adminNovember 2, 2025May 25, 2026
Inglos Biopharma reports positive clinical data on MSC therapy for stroke | IGC 2025 10th Annual Conference on Cell and Derivative Research and Industrializationby adminOctober 31, 2025May 25, 2026
Experts from Ingenics attended the first Conference on Stem Cell, Gene Therapy and Precision Medicine and delivered keynote speeches | Event Recapby adminOctober 20, 2025May 25, 2026
Incor Biotech wins three awards in the Top 50 Biotechnology Innovation in the Guangdong-Hong Kong-Macao Greater Bay Area; Phase II clinical trials of its MSC drug WG103 progress rapidly.by adminOctober 18, 2025May 25, 2026
